Search - tctmd.com

Displaying 1 - 20 of 90

Sort: Relevancy | Date

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Caitlin E. Cox

December 13, 2017

News Daily News

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

Yael L. Maxwell

December 01, 2017

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

Presentation Cardiovascular Interventions 2017

How Me The Data: Key Clinical Trials of 2017

Presenter: Curtiss T. Stinis

November 09, 2017

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

News Conference News TCT 2017

Early Pilot Study Results Show Symptom Improvement With TMVR

Michael O'Riordan

November 07, 2017

News Conference News TCT 2017

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

TCT Daily Staff

November 06, 2017

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

Presentation TCT 2017

PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation

Presenter: Saibal Kar

November 02, 2017

Presentation TCT 2017

TRIGUARD Design Features and Clinical Findings From EU Clinical Trials

Presenter: Joachim Schofer

October 31, 2017

Presentation TCT 2017

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Samir R. Kapadia

October 31, 2017

Presentation TCT 2017

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Presenter: Howard C. Herrmann, Michael J. Mack

October 31, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

Amulet: Data Synthesis and Ongoing Trials

Presenter: William A. Gray, Vivek Y. Reddy, Fabian Nietlispach

October 30, 2017

Presentation TCT 2017

WATCHMAN: Data Synthesis and Ongoing Trials

Presenter: William A. Gray, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions?

Presenter: William A. Gray, Vivek Y. Reddy, C. Michael Gibson

October 30, 2017

Presentation TCT 2017

Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions?

Presenter: William A. Gray, Vivek Y. Reddy, Kurt Huber

October 30, 2017

Advertisement

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Isolated Tricuspid Valve Surgery Remains Rare and Risky

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

How Me The Data: Key Clinical Trials of 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Early Pilot Study Results Show Symptom Improvement With TMVR

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation

TRIGUARD Design Features and Clinical Findings From EU Clinical Trials

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Amulet: Data Synthesis and Ongoing Trials

WATCHMAN: Data Synthesis and Ongoing Trials

Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions?

Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content